Targeting apoptosis defects in cutaneous T-cell lymphoma
1Dermatology Department, University Hospital, Zürich, Switzerland.
The Journal of Investigative Dermatology
|April 17, 2009
Summary
Cutaneous T-cell lymphomas (CTCLs) show impaired Fas expression, hindering T-cell apoptosis. Restoring Fas in CTCL cells re-sensitizes them to apoptosis, offering new therapeutic strategies.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Cutaneous T-cell lymphomas (CTCLs) involve abnormal T-lymphocyte proliferation in the skin.
- T-cell homeostasis relies on Fas-mediated apoptosis, which appears defective in CTCL.
- Reduced Fas expression is observed in CTCL tumors, potentially linked to apoptosis inhibitor overexpression.
Purpose of the Study:
- To investigate the role of Fas expression in CTCL pathogenesis.
- To explore the therapeutic potential of restoring Fas function in CTCL cells.
Main Methods:
- Analysis of Fas expression in CTCL cells.
- Genetic engineering of CTCL cells to re-express Fas.
- Assessment of FasL-induced apoptosis in modified CTCL cells.
Main Results:
- Confirmed impaired Fas expression in CTCL cells.
- Demonstrated that re-expression of Fas restores sensitivity to FasL-induced apoptosis.
- Identified a potential mechanism for T-cell accumulation in CTCL.
Conclusions:
- Impaired Fas expression is a key feature of CTCL.
- Restoring Fas function represents a promising therapeutic strategy for CTCL.
- Targeting Fas-mediated apoptosis could offer new treatment avenues for CTCL patients.
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
08:12Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.